An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models.

Dharmapuri S, Aurisicchio L, Neuner P, Verdirame M, Ciliberto G, La Monica N. (2009)
Cancer Gene Ther. 2009 May;16(5):462-72.